Amrutanjan Health Care Limited

NSEI:AMRUTANJAN 株式レポート

時価総額:₹20.3b

Amrutanjan Health Care 配当と自社株買い

配当金 基準チェック /46

Amrutanjan Health Care配当を支払う会社であり、現在の利回りは0.66%で、収益によって十分にカバーされています。

主要情報

0.7%

配当利回り

-0.07%

バイバック利回り

総株主利回り0.6%
将来の配当利回りn/a
配当成長-7.6%
次回配当支払日n/a
配当落ち日n/a
一株当たり配当金₹4.600
配当性向28%

最近の配当と自社株買いの更新

Amrutanjan Health Care (NSE:AMRUTANJAN) Is Paying Out A Dividend Of ₹1.00

Nov 19
Amrutanjan Health Care (NSE:AMRUTANJAN) Is Paying Out A Dividend Of ₹1.00

Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60

Aug 31
Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60

Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60

Aug 17
Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60

Recent updates

Amrutanjan Health Care (NSE:AMRUTANJAN) Is Paying Out A Dividend Of ₹1.00

Nov 19
Amrutanjan Health Care (NSE:AMRUTANJAN) Is Paying Out A Dividend Of ₹1.00

Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60

Aug 31
Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60

Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60

Aug 17
Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60

We Think You Should Be Aware Of Some Concerning Factors In Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings

May 31
We Think You Should Be Aware Of Some Concerning Factors In Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings

Pinning Down Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) P/E Is Difficult Right Now

May 03
Pinning Down Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) P/E Is Difficult Right Now

Amrutanjan Health Care (NSE:AMRUTANJAN) Has Affirmed Its Dividend Of ₹1.00

Feb 12
Amrutanjan Health Care (NSE:AMRUTANJAN) Has Affirmed Its Dividend Of ₹1.00

Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹2.60

Sep 02
Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹2.60

Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60

Aug 19
Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60

Amrutanjan Health Care (NSE:AMRUTANJAN) Is Due To Pay A Dividend Of ₹2.60

Aug 05
Amrutanjan Health Care (NSE:AMRUTANJAN) Is Due To Pay A Dividend Of ₹2.60

Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹1.00

Feb 17
Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹1.00

Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹1.00

Nov 08
Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹1.00

Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹2.60

Aug 18
Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹2.60

Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Vies For A Place In Your Dividend Portfolio: Here's Why

Apr 30
Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Vies For A Place In Your Dividend Portfolio: Here's Why

Should You Be Adding Amrutanjan Health Care (NSE:AMRUTANJAN) To Your Watchlist Today?

Apr 08
Should You Be Adding Amrutanjan Health Care (NSE:AMRUTANJAN) To Your Watchlist Today?

Introducing Amrutanjan Health Care (NSE:AMRUTANJAN), The Stock That Zoomed 162% In The Last Five Years

Mar 11
Introducing Amrutanjan Health Care (NSE:AMRUTANJAN), The Stock That Zoomed 162% In The Last Five Years

Trade Alert: The Non-Executive Independent Director Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN), Govindan Raghavan, Has Just Spent ₹72k Buying A Few More Shares

Feb 24
Trade Alert: The Non-Executive Independent Director Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN), Govindan Raghavan, Has Just Spent ₹72k Buying A Few More Shares

Is It Smart To Buy Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Before It Goes Ex-Dividend?

Feb 14
Is It Smart To Buy Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Before It Goes Ex-Dividend?

Is Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Latest Stock Performance A Reflection Of Its Financial Health?

Feb 12
Is Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Latest Stock Performance A Reflection Of Its Financial Health?

Is Amrutanjan Health Care Limited (NSE:AMRUTANJAN) A Smart Choice For Dividend Investors?

Jan 30
Is Amrutanjan Health Care Limited (NSE:AMRUTANJAN) A Smart Choice For Dividend Investors?

Is There More To The Story Than Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings Growth?

Jan 17
Is There More To The Story Than Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings Growth?

Here's Why I Think Amrutanjan Health Care (NSE:AMRUTANJAN) Is An Interesting Stock

Jan 04
Here's Why I Think Amrutanjan Health Care (NSE:AMRUTANJAN) Is An Interesting Stock

What Type Of Shareholders Make Up Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Share Registry?

Dec 22
What Type Of Shareholders Make Up Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Share Registry?

How Much is Amrutanjan Health Care's (NSE:AMRUTANJAN) CEO Getting Paid?

Dec 09
How Much is Amrutanjan Health Care's (NSE:AMRUTANJAN) CEO Getting Paid?

If You Had Bought Amrutanjan Health Care (NSE:AMRUTANJAN) Stock Five Years Ago, You Could Pocket A 106% Gain Today

Nov 26
If You Had Bought Amrutanjan Health Care (NSE:AMRUTANJAN) Stock Five Years Ago, You Could Pocket A 106% Gain Today

Here's What We Like About Amrutanjan Health Care's (NSE:AMRUTANJAN) Upcoming Dividend

Nov 14
Here's What We Like About Amrutanjan Health Care's (NSE:AMRUTANJAN) Upcoming Dividend

Why Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Should Be In Your Dividend Portfolio

Oct 28
Why Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Should Be In Your Dividend Portfolio

Are Strong Financial Prospects The Force That Is Driving The Momentum In Amrutanjan Health Care Limited's NSE:AMRUTANJAN) Stock?

Oct 10
Are Strong Financial Prospects The Force That Is Driving The Momentum In Amrutanjan Health Care Limited's NSE:AMRUTANJAN) Stock?

I Ran A Stock Scan For Earnings Growth And Amrutanjan Health Care (NSE:AMRUTANJAN) Passed With Ease

Sep 22
I Ran A Stock Scan For Earnings Growth And Amrutanjan Health Care (NSE:AMRUTANJAN) Passed With Ease

What Percentage Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares Do Insiders Own?

Sep 01
What Percentage Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares Do Insiders Own?

With Amrutanjan Health Care Limited (NSE:AMRUTANJAN) It Looks Like You'll Get What You Pay For

Aug 11
With Amrutanjan Health Care Limited (NSE:AMRUTANJAN) It Looks Like You'll Get What You Pay For

Have Insiders Been Selling Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares?

Jul 29
Have Insiders Been Selling Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares?

決済の安定と成長

配当データの取得

安定した配当: AMRUTANJANの配当金支払いは、過去10年間 変動性 が高かった。

増加する配当: AMRUTANJANの配当金は過去10年間にわたって増加しています。


配当利回り対市場

Amrutanjan Health Care 配当利回り対市場
AMRUTANJAN 配当利回りは市場と比べてどうか?
セグメント配当利回り
会社 (AMRUTANJAN)0.7%
市場下位25% (IN)0.2%
市場トップ25% (IN)1.2%
業界平均 (Pharmaceuticals)0.7%
アナリスト予想 (AMRUTANJAN) (最長3年)n/a

注目すべき配当: AMRUTANJANの配当金 ( 0.66% ) はIndian市場の配当金支払者の下位 25% ( 0.24% ) よりも高くなっています。

高配当: AMRUTANJANの配当金 ( 0.66% ) はIndian市場の配当金支払者の上位 25% ( 1.14% ) と比較すると低いです。


株主への利益配当

収益カバレッジ: AMRUTANJANの 配当性向 ( 28% ) はかなり低いため、配当金の支払いは利益によって十分にカバーされます。


株主配当金

キャッシュフローカバレッジ: AMRUTANJANは合理的な 現金配当性向 ( 73.3% ) を備えているため、配当金の支払いはキャッシュフローによって賄われます。


高配当企業の発掘

企業分析と財務データの現状

データ最終更新日(UTC時間)
企業分析2025/01/10 02:52
終値2025/01/10 00:00
収益2024/09/30
年間収益2024/03/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
市場価格30年
  • 株価
  • 配当、分割、措置
所有権10年
  • トップ株主
  • インサイダー取引
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
主な進展10年
  • 会社からのお知らせ

* 米国証券を例とし、非米国証券については同等の規制書式と情報源を使用

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM(Trailing Twelve Month)またはLTM(Last Twelve Month)データとして知られています。詳細はこちら

分析モデルとスノーフレーク

このレポートの作成に使用した分析モデルの詳細は、Githubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeでのチュートリアルもご用意しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

Amrutanjan Health Care Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2

アナリスト機関
Pranoy KurianCentrum Broking (Non-Insti) Clients
Harini V.FirstCall Research